Navigation Links
Wyle Personnel Take Part in Important Studies Aboard the International Space Station
Date:11/16/2009

EL SEGUNDO, Calif., Nov. 16 /PRNewswire/ -- Medical and technical experts at Wyle are assisting two important NASA projects on the International Space Station. Their efforts will help astronauts cope with effects of long-duration spaceflight similar to what might be experienced in a future mission to Mars.

"If successful, these studies will both improve astronaut health during space exploration missions and provide us with better insight into cardiovascular function here on Earth," said Dr. Douglas Hamilton, one of the senior investigators on the studies.

Wyle personnel include Dr. Douglas Ebert, Dr. Hamilton, and Dr. Ashot Sargsyan and sonographers Kathleen Garcia, David Martin and Suzanne Poston. They provide ultrasound, telemedicine, cardiovascular and project management expertise for the project, which will develop a remotely-guided ultrasound methodology and evaluate cardiovascular function and adaptation to microgravity.

On Earth, ultrasound scans are typically performed by experienced technicians and interpreted by physicians. In space, it is necessary for crewmembers, who have little or no ultrasound experience, to perform these scans on themselves or on each other. Remote guidance telemedicine techniques used on the International Space Station allow astronauts to perform these exams in space and send the scans to Earth for interpretation by medical professionals.

The problem is made even more difficult by the behavior of fluids, organs and soft tissue in weightlessness. Diagnostic imaging on earth uses gravity-based imaging techniques because gravity plays a significant role in the location of fluids and soft tissue. In microgravity, the distribution of fluid is determined by a combination of other factors like surface tension, pressure gradients and tissue and organ compliance.

The first project uses a Russian occlusion cuff system to acutely alter volume distribution in crewmembers while focused ultrasound measurement techniques are developed. These new techniques will more accurately measure space-induced fluid volume shifts, enhance the diagnostic value of ultrasounds performed in space, and advance telemedicine capabilities.

Data will provide insights into the cardiovascular system's response to circulating volume changes and provide important insights into basic cardiovascular research here on Earth, too. The investigation is sponsored by NASA and the Russian Federal Space Agency in collaboration with Dr. Scott Dulchavsky from Henry Ford Health System. Funding for the project is provided as part of NASA's Human Research Program.

The second project investigates changes in heart size and function following long duration exposure to microgravity. Blood pressure and electrocardiogram (ECG) readings are evaluated at several time points before, during, and following spaceflight.

The study also obtains comprehensive in-flight cardiac imaging data. Images of the heart coupled with electrocardiography and pre- and post-flight magnetic resonance imaging (MRI) provide critical information in establishing a "space normal" pattern for hearts and lets researchers evaluate cardiac function during long duration spaceflight.

Dr. Michael W. Bungo of the University of Texas, Houston Medical School and chief of staff at LBJ Hospital and Dr. Benjamin D. Levine, director of the Institute for Exercise and Environmental Medicine, University of Texas Southwestern Medical Center at Dallas, are principal investigators for the study, joined by Dr. Hamilton of Wyle and Dr. Smith Johnston of NASA as co-investigators.

Wyle provides NASA's human space missions with biomedical and engineering services as part of a portfolio of science, information technology and engineering services to the federal government on long-term outsourcing contracts. Wyle also tests and evaluates aircraft, weapon systems, networks, and other government assets, and provides engineering services to the aerospace, defense, and nuclear power industries.

    Contact:
    Dan Reeder
    (310) 563-6834
    Ref.:  NR/09-24

SOURCE Wyle


'/>"/>
SOURCE Wyle
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Senetek PLC Announces Appointments of Key Personnel
2. bioMETRX, Inc. Initiates Integration of Personnel and Assets of Sequiam Corp.
3. Texcel Medical Expands Medical Device Development & Manufacturing Capabilities With New Personnel, Nearly $1 Million in Capital Investments
4. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
5. 454 Sequencing(TM): Science Paper Suggests That Structural Variation Plays an Important Role in Genetic Variation
6. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
7. Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services
8. Off-Label Stent Use: How Important Are FDA Approvals to Physicians?
9. AMT Makes Important Advance in the Development of its Gene Therapy for Hemophilia B -Company Accesses Technology to Prevent Immune Response
10. Silence Obtains Important Patent Protection for Lead Internal Development Compound, Atu027
11. Mymetics Corporation Important Shareholders Information Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):